4/26/2013

The T2Candida rapid blood test created by T2 Biosystems may significantly reduce mortality rates for patients diagnosed with Candida infection, which is the fourth-highest cause of hospital-acquired infections, researchers reported in Science Translational Medicine. Study investigator Dr. Eleftherios Mylonakis of Brown University said time to diagnosis is an important factor in Candida-related mortality and each hour of delay increases the risk.

Related Summaries